» Articles » PMID: 28933590

RUBCN/rubicon and EGFR Regulate Lysosomal Degradative Processes in the Retinal Pigment Epithelium (RPE) of the Eye

Overview
Journal Autophagy
Specialty Cell Biology
Date 2017 Sep 22
PMID 28933590
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Macroautophagy/autophagy is an intracellular stress survival and recycling system whereas phagocytosis internalizes material from the extracellular milieu; yet, both pathways utilize lysosomes for cargo degradation. Whereas autophagy occurs in all cells, phagocytosis is performed by cell types such as macrophages and the retinal pigment epithelial (RPE) cells of the eye where it is supported by the noncanonical autophagy process termed LC3-associated phagocytosis (LAP). Autophagy and LAP are distinct pathways that use many of the same mediators and must compete for cellular resources, suggesting that cells may regulate both processes under homeostatic and stress conditions. Our data reveal that RPE cells promote LAP through the expression of RUBCN/Rubicon (RUN domain and cysteine-rich domain containing Beclin 1-interacting protein) and suppress autophagy through the activation of EGFR (epidermal growth factor receptor). In the morning when photoreceptor outer segments (POS) phagocytosis and LAP are highest, RUBCN expression is increased. At the same time, outer segment phagocytosis activates the EGFR resulting in MTOR (mechanistic target of rapamycin [serine/threonine kinase]) stimulation, the accumulation of SQSTM1/p62, and the phosphorylation of BECN1 (Beclin 1, autophagy related) on an inhibitory residue thereby suppressing autophagy. Silencing Rubcn, preventing EGFR activity or directly inducing autophagy in RPE cells by starvation inhibits phagocytic degradation of POS. Thus, RPE cells regulate lysosomal pathways during the critical period of POS phagocytosis to support retinal homeostasis.

Citing Articles

Retinal Pigment Epithelium Under Oxidative Stress: Chaperoning Autophagy and Beyond.

Markitantova Y, Simirskii V Int J Mol Sci. 2025; 26(3).

PMID: 39940964 PMC: 11818496. DOI: 10.3390/ijms26031193.


Ezrin defines TSC complex activation at endosomal compartments through EGFR-AKT signaling.

Giamundo G, Intartaglia D, Del Prete E, Polishchuk E, Andreone F, Ognibene M Elife. 2025; 13.

PMID: 39937579 PMC: 11820125. DOI: 10.7554/eLife.98523.


Oroxylin A-induced Trained Immunity Promotes LC3-associated Phagocytosis in Macrophage in Protecting Mice Against Sepsis.

Yin L, Bing Z, Zheng Y, Pan Y, Dong Y, Wang J Inflammation. 2024; 47(6):2196-2214.

PMID: 38739341 DOI: 10.1007/s10753-024-02033-2.


The murine retinal pigment epithelium requires peroxisomal β-oxidation to maintain lysosomal function and prevent dedifferentiation.

Kocherlakota S, Das Y, Swinkels D, Vanmunster M, Callens M, Vinckier S Proc Natl Acad Sci U S A. 2023; 120(43):e2301733120.

PMID: 37862382 PMC: 10614831. DOI: 10.1073/pnas.2301733120.


mTORC1 Signaling and Negative Lens-Induced Axial Elongation.

Zhang R, Dong L, Wu H, Shi X, Zhou W, Li H Invest Ophthalmol Vis Sci. 2023; 64(10):24.

PMID: 37466949 PMC: 10362919. DOI: 10.1167/iovs.64.10.24.


References
1.
Valapala M, Wilson C, Hose S, Bhutto I, Grebe R, Dong A . Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1 signaling. Autophagy. 2014; 10(3):480-96. PMC: 4077886. DOI: 10.4161/auto.27292. View

2.
Young R, Bok D . Participation of the retinal pigment epithelium in the rod outer segment renewal process. J Cell Biol. 1969; 42(2):392-403. PMC: 2107669. DOI: 10.1083/jcb.42.2.392. View

3.
Yang C, Lee J, Rodgers M, Min C, Lee J, Kim H . Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation. Cell Host Microbe. 2012; 11(3):264-76. PMC: 3616771. DOI: 10.1016/j.chom.2012.01.018. View

4.
Zarbin M . Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004; 122(4):598-614. DOI: 10.1001/archopht.122.4.598. View

5.
Soulieres D, Senzer N, Vokes E, Hidalgo M, Agarwala S, Siu L . Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck. J Clin Oncol. 2004; 22(1):77-85. DOI: 10.1200/JCO.2004.06.075. View